People · Operator
Named in public records as an officer, director or promoter · active 2025–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| SRT Therapeutics, Inc. | — | Biotechnology | Series C | $47.4M | $316.4M | 2025 |
Ed Prunchunas at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ed Prunchunas on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Walsh | 1 | 24 |
| Lauren Otsuki | 1 | 4 |
| Shierley Widjaja | 1 | 3 |
| Rolf Benirschke | 1 | 2 |
| Brian G. Feagan, M.D. | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.